1. Department of Clinical Oncology, Beijing Cancer Hospital, Beijing, China;
2. Department of Oncology, Shanghai General Hospital, Shanghai, China;
3. Department of Oncology, The First People’s Hospital of Foshan, Foshan, Guangdong, China;
4. Department of Oncology, Jiangsu Province Hospital, Nanjing, China;
5. Xijing Hospital, Fourth Military Medical University, Xi’an, China;
6. Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China;
7. Department of Oncology, Guangdong General Hospital, Guangzhou, Guangdong, China;
8. Department of Medical Oncology, Fujian Medical University Union Hospital, Xiamen, Fujian, China;
9. Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China;
10. School of Medicine, The First Hospital of Zhejiang Province, Hangzhou, Zhejiang, China;
11. Health Economics and Outcomes Research, Eli Lilly and Company China Affiliate, Shanghai, China;
12. Real World Insights, IQVIA, Shanghai, China;
13. Real World Insights, IQVIA, Beijing, China;
14. Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China